(Total Views: 368)
Posted On: 11/21/2018 10:04:14 AM
Post# of 72443
Galera Phase 3 oral Mucositis.
I was just looking at their trial and was surprised to see this.
"The purpose of the phase 3, clinical study is to determine if GC4419 administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck."
So they aren't looking to reduce occurrences just severity?
Also their patient population # is 335.
With a proven rinse and spit and with a BP, IPIX can do this in a year or less.
B-OM will OWN the entire BILLION dollar market!!!!
I was just looking at their trial and was surprised to see this.
"The purpose of the phase 3, clinical study is to determine if GC4419 administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck."
So they aren't looking to reduce occurrences just severity?
Also their patient population # is 335.
With a proven rinse and spit and with a BP, IPIX can do this in a year or less.
B-OM will OWN the entire BILLION dollar market!!!!
(4)
(0)Scroll down for more posts ▼
